Darling Ingredients stock (US2372661015): U.S. patent win for Nextida GC puts health-ingredients pipeline in focus

Darling Ingredients shares trade on the NYSE while the U.S. Patent and Trademark Office grants a new patent for the company’s Rousselot collagen peptide Nextida GC, highlighting the Texas-based group’s push into science-backed metabolic health ingredients.

Darling Ingredients stock is trading in the United States on the New York Stock Exchange under the ticker DAR as the company highlights a new intellectual-property milestone for its health brand Rousselot, with the U.S. Patent and Trademark Office granting Patent No. US12636339 for the Nextida GC collagen peptide ingredient designed to support post-meal blood sugar levels, according to a Business Wire release dated 05/20/2025 and republished by Stock Titan (Business Wire via Stock Titan as of 05/20/2025).

The patent for Nextida GC covers both the production process and its use as a dietary supplement ingredient, positioning Darling Ingredients in the United States as a provider of a non-pharmaceutical option for managing blood glucose through nutrition, with the Rousselot portfolio aimed at functional health applications, as outlined in the same 05/20/2025 announcement (Business Wire via Stock Titan as of 05/20/2025).

As of: 06/04/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: DAR
• Sector/industry: Sustainable ingredients and bio-nutrients
• Headquarters/country: Irving, United States
• Core markets: North America, Europe, South America, China and selected international regions
• Key revenue drivers: Rendered animal by-products, specialty food and feed ingredients, renewable fuels feedstocks and collagen-based health ingredients
• Home exchange/listing venue: New York Stock Exchange (DAR)
• Trading currency: USD

Darling Ingredients: core business model

Darling Ingredients converts animal agriculture and food-industry by-products into a range of sustainable ingredients, with earnings largely supported by demand for feed, food and fuel inputs as well as growing health-oriented collagen offerings such as those marketed under the Rousselot brand.

Industry trends and competitive position

In the wider ingredients and specialty nutrition space, Darling Ingredients participates in a market where investors often compare it to peers that supply functional and value-added inputs to food and personal-care brands; a recent Q1 industry review published by StockStory on TradingView on 05/13/2025 highlighted that Darling Ingredients generated quarterly revenue of USD 1.55 billion, an increase of 12.3% year on year, which was broadly in line with analysts’ expectations for the sector (StockStory on TradingView as of 05/13/2025).

The same 05/13/2025 sector note described the ingredients, flavors and fragrances cohort as growing at differing speeds, with Darling Ingredients’ 12.3% year-on-year revenue expansion to USD 1.55 billion in Q1 positioning it around the middle of the peer group in terms of top-line growth, underscoring how the company’s exposure to animal by-products, used cooking oil and collagen-based health products links it to both traditional agriculture cycles and emerging demand for science-supported functional nutrition (StockStory on TradingView as of 05/13/2025).

Conclusion

The focus for Darling Ingredients today centers on its home U.S. market and the expansion of its intellectual-property base, exemplified by the U.S. patent granted on 05/20/2025 for the Rousselot Nextida GC collagen peptide aimed at supporting post-meal blood sugar levels. Within the broader ingredients and specialty nutrition industry, the company’s Q1 revenue of USD 1.55 billion and 12.3% year-on-year growth rate reported in an industry review on 05/13/2025 suggest it remains closely tied to both traditional rendering activities and newer segments such as functional health ingredients. For investors, the combination of a science-driven product pipeline and exposure to cyclical demand in feed, food and fuel inputs provides multiple levers that could influence how the DAR share price on the NYSE behaves over time.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.